Double Digit NASDAQ Stock Winners: ISEE, FAMI, AFRM
8:01 am Monday, September 13th, 2021
Following are major stock gainers on Nasdaq in Friday’s trading session:
IVERIC bio, Inc. (NASDAQ:ISEE) was the active stock gainer on Friday and soared 62% to $14.12. Iveric Bio didn’t have anything to say about Zimura, its lead candidate for the treatment of geographic atrophy secondary to age-related macular degeneration. The stock is shooting higher today in response to mixed pivotal trial results that Apellis Pharmaceuticals (NASDAQ:APLS) reported today.
Iveric Bio already reported success for Zimura in the pivotal Gather1 trial, but we’re still waiting for results from the Gather2 study. Today, Apellis Pharmaceuticals reported results for a pair of pivotal geographic atrophy studies with pegcetacoplan, and only one achieved statistical significance on its primary endpoint. This means Zumira could be the first geographic atrophy drug to earn FDA approval.
Farmmi, Inc. (NASDAQ:FAMI) stock surged 34.50% to $0.57. The company announced that it intends to offer in an underwritten public offering ordinary shares and pre-funded warrants to purchase ordinary shares (“Offering”). The pre-funded warrants shall be offered at the same price per share as the ordinary shares, less the $0.001 per share exercise price of each pre-funded warrant. The Company intends to use the net proceeds from this offering for general corporate and working capital needs and capital expenditures.
Affirm Holdings, Inc. (NASDAQ:AFRM) moved up 34% to $123.70 Friday after the ‘buy now, pay later’ network blasted Street sales estimates and forecast 2022 revenues of more than $1.1 billion.
Affirm said gross merchandise volumes for the three months ending in June, the group’s fiscal fourth quarter, more than doubled from the same period last year to $2.5 billion as its active customer base rose 97% to 7.1 million. Revenues from the fees it charges merchants to offer small ‘point of sale’ loans to its customers rose 70% to $261.8 million.
Looking into the 2022 financial year, Affirm said it sees gross merchandise volumes rising by a much as 70%, with revenues of between $1.16 billion and $1.19 billion, with both figures excluding the impact of its recent partnership with Amazon Inc. (AMZN).
